Orcam Financial Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Buy
1,541
+1
+0.1% +$233 0.27% 46
2025
Q4
$319K Sell
1,540
-160
-9% -$31.6K 0.24% 46
2025
Q3
$315K Buy
1,700
+350
+26% +$60K 0.25% 41
2025
Q2
$206K Hold
1,350
0.18% 49
2025
Q1
$224K Buy
+1,350
New +$211K 0.21% 45
2024
Q4
Sell
-1,350
Closed -$219K 46
2024
Q3
$219K Buy
+1,350
New +$215K 0.21% 45
2024
Q2
Sell
-1,350
Closed -$214K 43
2024
Q1
$214K Hold
1,350
0.23% 39
2023
Q4
$212K Hold
1,350
0.26% 35
2023
Q3
$210K Hold
1,350
0.28% 34
2023
Q2
$223K Sell
1,350
-19
-1% -$3.07K 0.31% 31
2023
Q1
$212K Buy
1,369
+19
+1% +$3.07K 0.29% 33
2022
Q4
$238K Hold
1,350
0.37% 29
2022
Q3
$221K Hold
1,350
0.38% 24
2022
Q2
$240K Hold
1,350
0.38% 25
2022
Q1
$239K Hold
1,350
0.34% 28
2021
Q4
$231K Buy
+1,350
New +$221K 0.32% 30

Other funds holding JNJ

Orcam Financial Group's JNJ Position: Q1 2026 in Review

Orcam Financial Group increased its Johnson & Johnson (JNJ) stake by 0.06% in Q1 2026, buying an estimated $233 and bringing the position to 1,541 shares worth $377K. The position accounts for 0.27% of the portfolio, ranked #46.

Orcam Financial Group first reported a position in JNJ in Q4 2021 and has held it in 16 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Orcam Financial Group held 1,541 shares of Johnson & Johnson worth $377K as of Q1 2026.
  • Orcam Financial Group bought 1 Johnson & Johnson share in Q1 2026, an estimated $233.
  • Johnson & Johnson made up 0.27% of Orcam Financial Group's portfolio in Q1 2026, its #46 holding.
  • Orcam Financial Group first reported a position in Johnson & Johnson in Q4 2021 and has held it in 16 quarters since.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Orcam Financial Group's 13F filing for Q1 2026, filed 12 May 2026.